| (210) | Number of the EPO application | 17885750 |
| (220) | Filing date of the EPO application | 2017.12.29 |
| (80) | EPO patent specification publication (B) | EPB nr. 11/2024, 2024.03.13 |
| (110) | EPO patent number | 3562486 |
| (21) | Number of the application | e 2019 1274 |
| (71) | Name(s) of applicant(s), code of the country | Bioxcel Therapeutics, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | NANDABALAN Krishnan, US;
YOCCA Frank, US;
SHARMA Sameer, US; |
| (73) | Name(s) of owner(s), code of the country | BioXcel Therapeutics, Inc., US; |
| (54) | Title of the invention | USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATION |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 31/415 (2006.01.01); A61K 31/4174 (2006.01.01); A61K 45/06 (2006.01.01); A61K 47/10 (2017.01.01); A61P 25/00 (2006.01.01); A61K 9/20 (2006.01.01); A61K 9/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.12.31 |
| (30) | Priority | 201662441164 P, 2016.12.31, US; 201762471393 P, 2017.03.15, US; 201762542323 P, 2017.08.08, US |
| (86) | International application | PCT/US2017/069030, 2017.12.29 |
| (87) | International publication | WO 2018/126182, 2018.07.05 |